A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 19, 2024Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Idiopathic Pulmonary FibrosisLast Updated:March 19, 2024Not yet recruiting
Condition(s):Cystic Fibrosis; Colorectal Cancer; AdenomaLast Updated:March 8, 2024Recruiting
Condition(s):Idiopathic Pulmonary Fibrosis (IPF)Last Updated:January 16, 2024Recruiting
Condition(s):Sensorineural Hearing Loss; FibrosisLast Updated:February 1, 2023Recruiting
Condition(s):Idiopathic Pulmonary Fibrosis (IPF)Last Updated:December 26, 2023Recruiting
Condition(s):Idiopathic Pulmonary Fibrosis; Activity, MotorLast Updated:September 25, 2023Not yet recruiting
Condition(s):Cystic FibrosisLast Updated:September 2, 2022Not yet recruiting
Condition(s):Pulmonary FibrosisLast Updated:December 8, 2023Not yet recruiting
Condition(s):Idiopathic Pulmonary Fibrosis; Mechanical Ventilation Pressure HighLast Updated:March 18, 2024Recruiting
Condition(s):Cystic FibrosisLast Updated:December 16, 2022Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.